Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study.
Richard DescampsMouhamed Djahoum MoussaEmmanuel BesnierMarc-Olivier FischerSebastien PreauFabienne TamionCédric DaubinNicolas CousinAndré VincentelliJulien GoutayDamien du CheyronPublished in: Critical care (London, England) (2021)
In critically ill patients under ECMO, mean anti-Xa activity was an independent risk factor for hemorrhagic complications. Anticoagulation targets could be revised downward in both VV- and VA-ECMO.